These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26824522)

  • 1. Dual T-type and L-type calcium channel blocker exerts beneficial effects in attenuating cardiovascular dysfunction in iron-overloaded thalassaemic mice.
    Kumfu S; Chattipakorn SC; Fucharoen S; Chattipakorn N
    Exp Physiol; 2016 Apr; 101(4):521-39. PubMed ID: 26824522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the iron chelator deferiprone and the T-type calcium channel blocker efonidipine on cardiac function and Ca
    Khamseekaew J; Kumfu S; Palee S; Wongjaikam S; Srichairatanakool S; Fucharoen S; Chattipakorn SC; Chattipakorn N
    Cell Calcium; 2018 Jun; 72():18-25. PubMed ID: 29748130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-type calcium channel blockade improves survival and cardiovascular function in thalassemic mice.
    Kumfu S; Chattipakorn S; Chinda K; Fucharoen S; Chattipakorn N
    Eur J Haematol; 2012 Jun; 88(6):535-48. PubMed ID: 22404220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of iron overload, an iron chelator and a T-Type calcium channel blocker on cardiac mitochondrial biogenesis and mitochondrial dynamics in thalassemic mice.
    Khamseekaew J; Kumfu S; Wongjaikam S; Kerdphoo S; Jaiwongkam T; Srichairatanakool S; Fucharoen S; Chattipakorn SC; Chattipakorn N
    Eur J Pharmacol; 2017 Mar; 799():118-127. PubMed ID: 28192097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined iron chelator and T-type calcium channel blocker exerts greater efficacy on cardioprotection than monotherapy in iron-overload thalassemic mice.
    Kumfu S; Khamseekaew J; Palee S; Srichairatanakool S; Fucharoen S; Chattipakorn SC; Chattipakorn N
    Eur J Pharmacol; 2018 Mar; 822():43-50. PubMed ID: 29366843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deferiprone and efonidipine mitigated iron-overload induced neurotoxicity in wild-type and thalassemic mice.
    Sripetchwandee J; Khamseekaew J; Svasti S; Srichairatanakool S; Fucharoen S; Chattipakorn N; Chattipakorn SC
    Life Sci; 2019 Dec; 239():116878. PubMed ID: 31669736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferric iron uptake into cardiomyocytes of β-thalassemic mice is not through calcium channels.
    Kumfu S; Chattipakorn S; Fucharoen S; Chattipakorn N
    Drug Chem Toxicol; 2013 Jul; 36(3):329-34. PubMed ID: 23050671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of iron overload condition on liver toxicity and hepcidin/ferroportin expression in thalassemic mice.
    Kumfu S; Chattipakorn SC; Fucharoen S; Chattipakorn N
    Life Sci; 2016 Apr; 150():15-23. PubMed ID: 26921633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron overload and apoptosis of HL-1 cardiomyocytes: effects of calcium channel blockade.
    Chen MP; Cabantchik ZI; Chan S; Chan GC; Cheung YF
    PLoS One; 2014; 9(11):e112915. PubMed ID: 25390893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.
    Fisher SA; Brunskill SJ; Doree C; Gooding S; Chowdhury O; Roberts DJ
    Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD004450. PubMed ID: 23963793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoring the impaired cardiac calcium homeostasis and cardiac function in iron overload rats by the combined deferiprone and N-acetyl cysteine.
    Wongjaikam S; Kumfu S; Khamseekaew J; Chattipakorn SC; Chattipakorn N
    Sci Rep; 2017 Mar; 7():44460. PubMed ID: 28287621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Iron Chelator and Antioxidant Exerted Greater Efficacy on Cardioprotection Than Monotherapy in Iron-Overloaded Rats.
    Wongjaikam S; Kumfu S; Khamseekaew J; Sripetchwandee J; Srichairatanakool S; Fucharoen S; Chattipakorn SC; Chattipakorn N
    PLoS One; 2016; 11(7):e0159414. PubMed ID: 27428732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-type Ca2+ channel blockade prevents sudden death in mice with heart failure.
    Kinoshita H; Kuwahara K; Takano M; Arai Y; Kuwabara Y; Yasuno S; Nakagawa Y; Nakanishi M; Harada M; Fujiwara M; Murakami M; Ueshima K; Nakao K
    Circulation; 2009 Sep; 120(9):743-52. PubMed ID: 19687356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of lipocalin-2 improves cardiomyocyte viability under iron overload conditions via decreasing mitochondrial dysfunction and apoptosis.
    Kumfu S; Siri-Angkul N; Chattipakorn SC; Chattipakorn N
    J Cell Physiol; 2021 Jul; 236(7):5108-5120. PubMed ID: 33319934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of the dual L- and T-type Ca2+ channel blocker efonidipine on cardiomyopathic hamsters.
    Suzuki S; Ohkusa T; Ono K; Sato T; Yoshida MA; Yano M; Takebayashi S; Matsuzaki M
    Circ J; 2007 Dec; 71(12):1970-6. PubMed ID: 18037756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in iron overload therapies. prospects for effective use of deferiprone (L1), deferoxamine, the new experimental chelators ICL670, GT56-252, L1NA11 and their combinations.
    Kontoghiorghes GJ; Eracleous E; Economides C; Kolnagou A
    Curr Med Chem; 2005; 12(23):2663-81. PubMed ID: 16305464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of efonidipine on TGF-β1-induced cardiac fibrosis through Smad2-dependent pathway in rat cardiac fibroblasts.
    Lei B; Hitomi H; Mori T; Nagai Y; Deguchi K; Mori H; Masaki T; Nakano D; Kobori H; Kitaura Y; Nishiyama A
    J Pharmacol Sci; 2011; 117(2):98-105. PubMed ID: 21897055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of a novel combination of two oral chelators deferasirox/deferiprone over deferoxamine/deferiprone in severely iron overloaded young beta thalassemia major patients.
    Elalfy MS; Adly AM; Wali Y; Tony S; Samir A; Elhenawy YI
    Eur J Haematol; 2015 Nov; 95(5):411-20. PubMed ID: 25600572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of L-type calcium channel blocker (amlodipine) on myocardial iron deposition in patients with thalassaemia with moderate-to-severe myocardial iron deposition: protocol for a randomised, controlled trial.
    Shakoor A; Zahoor M; Sadaf A; Alvi N; Fadoo Z; Rizvi A; Quadri F; Tipoo FA; Khurshid M; Sajjad Z; Colan S; Hasan BS
    BMJ Open; 2014 Dec; 4(12):e005360. PubMed ID: 25492271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy.
    Sasaki H; Saiki A; Endo K; Ban N; Yamaguchi T; Kawana H; Nagayama D; Ohhira M; Oyama T; Miyashita Y; Shirai K
    J Atheroscler Thromb; 2009 Oct; 16(5):568-75. PubMed ID: 19749494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.